Edaravone Plays Protective Effects on LPS-Induced Microglia by Switching M1/M2 Phenotypes and Regulating NLRP3 Inflammasome Activation

The NLRP3 Inflammasome and Its Role in the Pathogenicity of Leukemia

(2021) Laura Urwanisch et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Gastrointestinal Dysfunction in Parkinson’s Disease

(2021) Casper Skjærbæk et al.   Journal of Clinical Medicine

Edaravone attenuates traumatic brain injury through anti‑inflammatory and anti‑oxidative modulation

(2019) Man Zhang et al.   Experimental and Therapeutic Medicine

Fyn amplifies NLRP3 inflammasome signaling in Parkinson's disease

(2019) Nikhil Panicker et al.   Aging-US

Protective effect of edaravone on blood-brain barrier by affecting NRF-2/HO-1 signaling pathway

(2019) Jing Liu et al.   Experimental and Therapeutic Medicine

Parkinson’s Disease: A Systemic Inflammatory Disease Accompanied by Bacterial Inflammagens

(2019) Büin Adams et al.   Frontiers in Aging Neuroscience

Neuroprotective effects of silibinin: an in silico and in vitro study

(2018) Valencia Fernandes et al.   INTERNATIONAL JOURNAL OF NEUROSCIENCE

Enhancement of antitumor activity by using 5-ALA–mediated sonodynamic therapy to induce apoptosis in malignant gliomas: significance of high-intensity focused ultrasound on 5-ALA-SDT in a mouse glioma model

(2018) Satoshi Suehiro et al.   JOURNAL OF NEUROSURGERY

Astaxanthin ameliorates behavioral and biochemical alterations in in-vitro and in-vivo model of neuropathic pain

(2018) Kuhu Sharma et al.   NEUROSCIENCE LETTERS

Modulation of NLRP3 inflammasome activation in human monocytes by mitochondria-targeted superoxide and hydrogen sulphide

(2018) R. Abas et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease

(2018) Shuo Wang et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Parkinson disease

(2017) Werner Poewe et al.   Nature Reviews Disease Primers

Caspase-1 Deficiency Alleviates Dopaminergic Neuronal Death via Inhibiting Caspase-7/AIF Pathway in MPTP/p Mouse Model of Parkinson’s Disease

(2016) Chen Qiao et al.   MOLECULAR NEUROBIOLOGY

Dopamine Controls Systemic Inflammation through Inhibition of NLRP3 Inflammasome

(2015) Yiqing Yan et al.   CELL

M1 and M2 immune activation in Parkinson’s Disease: Foe and ally?

(2015) M.S. Moehle et al.   NEUROSCIENCE

NLRP3 Inflammasome Is Expressed and Functional in Mouse Brain Microglia but Not in Astrocytes

(2015) Audrey Gustin et al.   PLoS One

Modulating the delicate glial–neuronal interactions in neuropathic pain: Promises and potential caveats

(2014) Vinod Tiwari et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Platelet activating factor induces transient blood-brain barrier opening to facilitate edaravone penetration into the brain

(2013) Weirong Fang et al.   JOURNAL OF NEUROCHEMISTRY

Cytokines and Chemokines at the Crossroads of Neuroinflammation, Neurodegeneration, and Neuropathic Pain

(2013) Geeta Ramesh et al.   MEDIATORS OF INFLAMMATION

Triggering of Inflammasome by Aggregated α–Synuclein, an Inflammatory Response in Synucleinopathies

(2013) Gaia Codolo et al.   PLoS One

Macrophage plasticity and polarization: in vivo veritas

(2012) Antonio Sica et al.   JOURNAL OF CLINICAL INVESTIGATION

Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson's disease

(2009) Katharina Faust et al.   BMC NEUROSCIENCE

Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons

(2008) Wen Ji Yuan et al.   BMC NEUROSCIENCE

Parkinson's disease: clinical features and diagnosis

(2008) J Jankovic   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY